SST2 may bind free IL-33, substantially reducing the amount of IL-33 accessible for ST2L binding, attenuating the cardioprotective effect of IL-33, and ultimately contributing to myocardial fibrosis (Figure 4) (40). Here, IL33 is linked to Myocardial fibrosis.